Generics - Respiratory and Pulmonary, Mergers & Acquisitions

Filter

Popular Filters

Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis

03-04-2013

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) today (April 3) announced…

ActavisAstraZenecaDermatologicalsGenericsLegalMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalPulmicort RespulesRespiratory and PulmonaryValeant Pharmaceuticals

Back to top